Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
Dev Neurosci ; 45(2): 76-93, 2023.
Article in English | MEDLINE | ID: mdl-36436500

ABSTRACT

Hypoxic-ischaemic encephalopathy (HIE) in the newborn baby is a major contributor to neonatal mortality and morbidity across the world. Therapeutic hypothermia (TH) is the current standard treatment for moderate to severe HIE, but not all babies benefit. Potential neuroprotective actions of progesterone (PROG) include anti-apoptotic, anti-inflammatory, and anti-oxidative effects and reduction of energy depletion, tissue/cellular oedema, and excitotoxicity. In pre-clinical studies of neonatal HIE, PROG has neuroprotective properties but has not been the subject of systematic review. Here, our objective was to evaluate the evidence base for PROG as a potential therapeutic agent in HIE. The PICO framework was used to define the following inclusion criteria. Population: human neonates with HIE/animal models of HIE; intervention: PROG +/- other agents; comparison: V.S. control; outcome: pathological, neurobehavioural, and mechanistic outcome measures. Medline, EMBASE, and CINHAL were then searched between August to October 2018 using pre-defined medical subject heading and keywords. Study inclusion, data extraction, and risk of bias (ROB) analysis using the SYRCLE ROB tool were carried out by two authors. 14 studies were included in the review. They typically displayed a high ROB. This systematic review suggests that PROG reduced neuropathology and reduced neurobehavioural deficits post-hypoxic-ischaemic (HI) insult in 8 and 3 studies, respectively. However, there was sex dimorphism in the effects of PROG. In addition, there are limitations and biases in these studies, and there remains a need for well-designed large pre-clinical studies with greater methodological quality to further inform the efficacy, safety, dose, timing, and frequency of PROG administration. With such data, large animal studies could be planned combining PROG administration with and without TH.


Subject(s)
Hypothermia, Induced , Hypoxia-Ischemia, Brain , Neuroprotective Agents , Animals , Infant, Newborn , Humans , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Hypoxia-Ischemia, Brain/pathology , Progesterone/pharmacology , Progesterone/therapeutic use , Neuroprotection
4.
BMJ ; 356: j1519, 2017 03 27.
Article in English | MEDLINE | ID: mdl-28348020
5.
Int J STD AIDS ; 27(13): 1213-1217, 2016 11.
Article in English | MEDLINE | ID: mdl-26474815

ABSTRACT

The 2008 UK syphilis guideline recommends infants born to women with any positive syphilis serology be followed up until both treponemal and nontreponemal tests are negative to exclude congenital syphilis, whereas Centers for Disease Control and Prevention guidelines recommend using only nontreponemal tests. Historically, we had low infant follow-up rates with no coherent pathways. We initiated a change in multidisciplinary team practice of infant testing for syphilis in 2011 and evaluated the results before and after by retrospective review of testing of infants born to women with positive syphilis serology between 2005 and 2012. A total of 28 infants' mothers were treated in pregnancy (termed 'high risk'); 26 had adequate treatment prior to pregnancy (termed 'low risk'). There was a significant increase in serological testing after 2011 compared with before (83% versus 48%; OR 5.07 [95% CI 1.22-22.77] p = 0.01) but mainly in low risk infants with no significant improvement in high risk infants who are the priority group. Using nontreponemal tests only in the infants would have reduced the tests required by at least 50%, allowing health resources to be concentrated on achieving adequate follow-up for those infants most at risk.


Subject(s)
Infectious Disease Transmission, Vertical/prevention & control , Mothers , Pregnancy Complications, Infectious/diagnosis , Syphilis, Congenital/prevention & control , Syphilis/diagnosis , Treponema pallidum/isolation & purification , Adult , Anti-Bacterial Agents/therapeutic use , Female , Follow-Up Studies , Humans , Infant , Pregnancy , Pregnancy Complications, Infectious/blood , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/microbiology , Pregnancy Outcome , Prenatal Care/methods , Retrospective Studies , Serologic Tests , Syphilis/drug therapy , Syphilis Serodiagnosis/methods , Treatment Outcome , Treponema pallidum/immunology
6.
Nutr Clin Pract ; 28(6): 753-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24177284

ABSTRACT

BACKGROUND: Soy-based intravenous fat emulsion (IVFE) is known to cause a rise in pulmonary artery pressure in the preterm infant, thought to be mediated through eicosanoid metabolites of linoleic acid. We compared the effect of soy-based IVFE and an olive-oil-based IVFE containing less than half the content of linoleic acid on pulmonary artery pressure and eicosanoid metabolites in preterm infants receiving parenteral nutrition. METHODS: In this pilot study at a regional neonatal intensive care unit (ICU), infants received either a soy-based or olive-oil-based IVFE as part of an otherwise identical feeding protocol. Pulmonary artery pressure and urinary thromboxane B2 and prostaglandin F1 alpha were measured at baseline and maximum lipid infusion. RESULTS: There was a greater fall in pulmonary artery pressure in the olive-oil-based IVFE group compared with the soy-based IVFE group. A decrease in urine thromboxane/prostaglandin F1 alpha ratio was seen only in the olive-oil-based IVFE group. CONCLUSIONS: In the parenterally fed preterm infant, an olive-oil-based IVFE may have a beneficial effect on pulmonary artery pressure when compared with soy-based IVFE. Effects on pulmonary vascular tone are likely to be mediated through alterations in eicosanoid metabolism. A randomized trial is warranted to compare the effects of different lipid emulsions.


Subject(s)
Dietary Fats/pharmacology , Eicosanoids/urine , Fat Emulsions, Intravenous/pharmacology , Infant, Premature , Parenteral Nutrition , Plant Oils/pharmacology , Pulmonary Artery/drug effects , Blood Pressure/drug effects , Hemodynamics , Humans , Infant , Infant Nutritional Physiological Phenomena , Infant, Newborn , Linoleic Acid/pharmacology , Olea/chemistry , Olive Oil , Pilot Projects , Plant Oils/chemistry , Prostaglandins F/blood , Pulmonary Artery/physiology , Soybean Oil/chemistry , Soybean Oil/pharmacology , Glycine max/chemistry , Thromboxane B2/urine
8.
Arch Dis Child Educ Pract Ed ; 96(4): 128-35, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21362690

ABSTRACT

Respiratory distress in a moderately preterm baby often presents diagnostic and management challenges to the attending paediatrician. Many of these babies will require little or no intervention, but it is known that early intervention in babies with acute respiratory distress often prevents further complications. Most current research evidence relates to extremely preterm newborns, yet moderately preterm infants are numerically far more common. This article explores the differential diagnosis of respiratory distress in this population and presents an evidence based approach to treatment.


Subject(s)
Infant, Premature , Respiratory Distress Syndrome, Newborn/therapy , Diagnosis, Differential , Humans , Infant, Newborn , Respiratory Distress Syndrome, Newborn/diagnosis , Respiratory Distress Syndrome, Newborn/drug therapy
9.
J Perinatol ; 23(5): 396-403, 2003.
Article in English | MEDLINE | ID: mdl-12847536

ABSTRACT

OBJECTIVE: To describe the nature and frequency of posterior fossa (PF) lesions in infants who underwent magnetic resonance (MR) brain imaging in the neonatal period and to correlate with cranial ultrasound (CUS) findings and clinical outcome. STUDY DESIGN: A retrospective review of all neonatal MR brain imaging from 1996 to 2001 (n=558). MR images, CUS and case notes were reviewed in infants with PF abnormality. RESULTS: A total of 20 infants had abnormalities in the PF, which represents 4.7% of abnormalities seen on MR. Out of 10, six term infants had PF extra-axial hemorrhage, three had cerebellar hypoplasia, while one had cerebellar hemorrhage. In the preterm, 8/10 lesions were unilateral; focal cerebellar hemorrhage was seen in 5/10 and extensive hemorrhage with secondary atrophy in 3/10. Out of 20, 17 infants also had supratentorial lesions. Out of 20, 19 had CUS performed, of which 7/19 showed PF abnormality. CONCLUSION: Intracerebellar hemorrhage was more common in preterm infants than in term infants. These hemorrhages tended to be focal, unilateral and were associated with atrophy.


Subject(s)
Brain Diseases/diagnosis , Cranial Fossa, Posterior/abnormalities , Cranial Fossa, Posterior/pathology , Infant, Premature , Magnetic Resonance Imaging , Birth Weight , Brain Diseases/epidemiology , Cerebral Hemorrhage/diagnosis , Cerebral Hemorrhage/epidemiology , Child Development/physiology , Cohort Studies , Developmental Disabilities/diagnosis , Developmental Disabilities/epidemiology , Female , Gestational Age , Humans , Incidence , Infant, Newborn , Male , Prognosis , Retrospective Studies , Risk Assessment , Sensitivity and Specificity , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL